Accordingly, we found that critical NER-associated genes (ERCC1, ERCC2/XPD, XPA, XPC) were downregulated in HNSCC patients compared with HC, thus explaining in part the reduced NER capacity of these patients. This evidence concerns the gene ERCC2 and head and neck squamous cell carcinoma.